Our journal is dedicated to the full spectrum of #bleedingdisorders – and we’re changing our name to reflect that. Introducing Bleeding Disorders: Care & Practice – the new name for The Journal of Haemophilia Practice

www.bdcpjournal.com

#BDCPjournal #haemophilia #VWD
#HemeSky #MedSky #BloodSky

Puncture wound fingering
#bloodplay #bloodkink #bloodsky #selfgore #feet #foot #footkink

Thank you to all readers, authors & reviewers who have shown continued trust in JHP this year. Our mission is to share expertise & experience in the bleeding disorder community. Watch out for our exciting new chapter!

#bleedingdisorders #research #haemophilia #VWD
#HemeSky #BloodSky #MedSky

It's that time of year again… What's in your #SpotifyWrapped? Haemcast is a 2025 Marathon, Talked About, & Most Shared Show! We call that recommended holiday listening. Tune in via your favourite platform or visit https://loom.ly/A4UWu6M

#bleedingdisorders #podcast
#HemeSky #BloodSky #MedSky

New in The Journal of Haemophilia Practice: results from a clinic-based questionnaire aimed at improving treatment of heavy menstrual bleeding in women with bleeding disorders

https://doi.org/10.2478/jhp-2025-0018

#HMB #periods #women #bleedingdisorders #research
#HemeSky #MedSky #BloodSky

What do recent changes to the WHO #EssentialMedicines List mean for #haemophilia on the ground? We asked the Haemophilia Foundation of Uganda's Agnes Kiskaye. Read her thoughts and hopes on the Haemnet blog: https://loom.ly/AB3rNJI

#HemeSky #MedSky #BloodSky

Being heard and understood? Getting advice and support? Meeting people like you? If you live with a bleeding disorder, what does community mean to you?

#bleedingdisorders #community #livedexperience #research #haemophilia #vonWillebrandDisease #GlanzmannThrombasthenia

#HemeSky #BloodSky

In an interview from #iwCLL2025, Nicolas Martinez-Calle provides insight into the UNCOVER project, which aims to evaluate inequalities in the diagnosis and survival of patients with CLL in England.

Watch here:

👉 buff.ly/FZdouqO 👈

#CLLsm #Leusm #Leukemia #HemOnc #BloodSky #HemeSky #MedSky

At #IMS25, we spoke with Lisa Leypoldt, who shared findings from the cytogenetic subgroup analyses of the Phase II GMMG-CONCEPT trial evaluating Isa-KRd in newly diagnosed #myeloma.

Click here to watch:

🎥 buff.ly/Ut0Ne7p

#MMSM #MultipleMyeloma #CTSM #ImmunoOnc #BloodSky #HemeSky #MedSky

Thank you to Ali Taher for speaking with us recently and providing valuable insight into the management of acute complications of #thalassemia that may present to the emergency department.

Watch the interview here:

👉 buff.ly/yL0drrc 👈

#Hematology #BloodSky #HemeSky #MedSky

🎥 Vanthana Bharathi of @mdanderson.bsky.social discusses optimizing preventive care for patients with CLL using evidence-based strategies:

👉 buff.ly/BKMPQGT 👈

#CLLsm #Leusm #Leukemia #HemOnc #iwCLL2025 #BloodSky #HemeSky #MedSky

In an interview from #SOHO2025, @krishpatelmd.bsky.social of @scri.com comments on the potential of NK cell-based therapies for B-cell lymphomas.

Click here to watch:

👉 buff.ly/jMYSlMT 👈

#LYMsm #Lymphoma #HemOnc #BloodSky #HemeSky #MedSky

Does anyone know of a good textbook/review broadly on erythropoiesis? I'd love to hear your suggestions! 🩸 #hemesky #bloodsky

What are the key risk factors for the development of bone disease in patients with #thalassemia? 🩸🦴

Julian Waung provided insight into this in a recent interview – watch here:

👉 buff.ly/Oe2kknT 👈

#Hematology #BloodSky #HemeSky #MedSky

🎥 Mazyar Shadman of @fredhutch.org presents the results of a post hoc analysis & MAIC comparing the outcomes of fit patients treated with zanubrutinib in the SEQUOIA trial to the outcomes of patients treated with AV in AMPLIFY:

👉 buff.ly/paPH5vx 👈

#CLLsm #iwCLL2025 #Leusm #CTSM #BloodSky #HemeSky

It was fantastic to catch up with @jmikhaelmd.bsky.social at #SOHO2025 to gain insight into areas of consensus & controversy in the current & future management of R/R #MultipleMyeloma!🩸

Watch the interview here:

👉 buff.ly/7AoA6tc 👈

#MMsm #Myeloma #ImmunoOnc #HemOnc #BloodSky #HemeSky #MedSky

Intergenerational impacts of the #ContaminatedBloodScandal, stakeholder roles in #patientorganisations in India, acquired haemophilia A, and #haemophilia clinical practice are the focus of the latest papers published in JHP. Find out more: https://loom.ly/mXzYdu4

#HemeSky #BloodSky #MedSky

In an interview from #iwAL25, Tara Lin discusses the possibility of tailoring treatment for secondary AML dependent on mutational profile, highlighting the heterogeneity of this disease.

Watch here:

👉 buff.ly/HbJTfmF 👈

#AMLsm #Leusm #Leukemia #HemOnc #BloodSky

It was great to catch up with the wonderful Anna Schuh at #iwCLL2025 to hear about ongoing efforts to improve the outcomes & care of patients with CLL in resource-limited settings.

Watch the interview here:

🎥 buff.ly/sZGLLe2

#CLLsm #Leusm #Leukemia #HemOnc #BloodSky #HemeSky #MedSky

We recently had the pleasure of interviewing the lovely Payal Desai to hear about several topics in the field of #SickleCellDisease, including the potential of the six-minute walk test as a prognostic tool. 🚶

Learn more here: 👉 buff.ly/iMa7wAa

#Hematology #BloodSky #HemeSky #MedSky

New music from Australia's #BloodSky! #PowerMetal that is not to be missed. Give a listen to "Relic"!

#metalsky #heavymetal #progressivemetal #powermetal

In a recent interview, Jesús San Miguel comments on the updated findings of the Phase III GEM2017FIT trial, which evaluated the efficacy of DaraKRd versus KRd in patients with newly diagnosed #MultipleMyeloma.

Click to watch:

👉 buff.ly/RVZjPoG 👈

#CTSM #TrialUpdate #IMS25 #MMsm #Myeloma #BloodSky

What should the optimal pre-transfusion hemoglobin target be in patients with thalassemia? 🤔🩸

We caught up with Maria Domenica Cappellini recently to find out!

Click here to watch the interview:

🎥 👉 buff.ly/B8HDjTL

#Thalassemia #Hematology #BloodSky #HemeSky #MedSky

#iwAL25 | John DiPersio comments on the challenges of treating T-cell malignancies with bispecific antibody therapy, and shares insights into the development of WU-CART-007, an anti-CD7 allogeneic CAR T-cell product:

🎥 buff.ly/s2zXiCa

#ALLsm #Leusm #ImmunoOnc #HemOnc #BloodSky #HemeSky #MedSky

It was fantastic to catch up with the lovely Meral Beksac at #IMS25 to hear about strategies for improving CAR T-cell responsiveness and overcoming resistance in patients with #MultipleMyeloma.

Watch the interview here:

🎥 buff.ly/Rm44VmO

#MMsm #Myeloma #CARTCell #ImmunoOnc #BloodSky #HemeSky